The story of Viagra, and its developer copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of https://bookmarkinglive.com/story22448277/sildenafil-and-big-pharma-a-risky-venture